Literature DB >> 18426524

Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.

Cindy K Blair1, Michelle Roesler, Yang Xie, Alan S Gamis, Andrew F Olshan, Nyla A Heerema, Leslie L Robison, Julie A Ross.   

Abstract

Vitamin supplements have been proposed for children with Down's syndrome (DS) with claims of improving cognitive abilities, or immune or thyroid function. Several studies have shown decreased levels of zinc in this population. Because children with DS have a 50-fold increased risk of developing acute leukaemia during the first 5 years of life, we explored the relation between child vitamin and herbal supplement use and the risk of leukaemia in a case-control study. During the period 1997-2002, we enrolled 158 children with DS aged 0-18 years that were diagnosed with acute lymphoblastic leukaemia (ALL) (n = 97) or acute myeloid leukaemia (AML) (n = 61) at participating Children's Oncology Group institutions. We enrolled 173 DS children without leukaemia (controls), selected from the cases' primary care clinic and frequency-matched on age. Data were collected via telephone interviews with mothers of the index child regarding use of multivitamins, zinc, vitamin C, iron and herbal supplements, including age at first use, frequency and duration. Among controls, 57% reported regular multivitamin use (>/=3 times/week for >/=3 months) compared with 48% of ALL cases and 61% of AML cases. We found no evidence of an association between children's regular multivitamin use and ALL or AML (adjusted odds ratios [OR] = 0.94 [95% CI 0.52, 1.70] and 1.90 [0.73, 4.91] respectively). There was a suggestion of an increased risk for AML associated with regular multivitamin use during the first year of life or for an extended duration (ORs = 2.38 [0.94, 5.76] and 2.59 [1.02, 6.59] respectively). Despite being the largest study of DS-leukaemia, our sample size was small, resulting in imprecise effect estimates. Future research should include larger sample sizes as well as a full assessment of diet including vitamin supplementation to adequately examine the relation between nutritional status and childhood leukaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426524      PMCID: PMC3365502          DOI: 10.1111/j.1365-3016.2008.00928.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  35 in total

1.  Vitamin-mineral supplement use among preschool children in the United States.

Authors:  S M Yu; M D Kogan; P Gergen
Journal:  Pediatrics       Date:  1997-11       Impact factor: 7.124

2.  Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988--94.

Authors:  R Bethene Ervin; Jacqueline D Wright; Debra Reed-Gillette
Journal:  Adv Data       Date:  2004-11-09

3.  Longitudinal patterns of vitamin and mineral supplement use in young white children.

Authors:  Julie M Eichenberger Gilmore; Liang Hong; Barbara Broffitt; Steven M Levy
Journal:  J Am Diet Assoc       Date:  2005-05

Review 4.  Micronutrients: dietary intake v. supplement use.

Authors:  Jayne V Woodside; Damian McCall; Claire McGartland; Ian S Young
Journal:  Proc Nutr Soc       Date:  2005-11       Impact factor: 6.297

5.  Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years.

Authors:  Susan N Van Cleve; William I Cohen
Journal:  J Pediatr Health Care       Date:  2006 Jan-Feb       Impact factor: 1.812

6.  Feeding Infants and Toddlers Study: do vitamin and mineral supplements contribute to nutrient adequacy or excess among US infants and toddlers?

Authors:  Ronette Briefel; Charlotte Hanson; Mary Kay Fox; Timothy Novak; Paula Ziegler
Journal:  J Am Diet Assoc       Date:  2006-01

7.  Periconceptional vitamin useand leukemia risk in children with Down syndrome: a Children's Oncology Group study.

Authors:  Julie A Ross; Cindy K Blair; Andrew F Olshan; Leslie L Robison; Franklin O Smith; Nyla A Heerema; Michelle Roesler
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

8.  Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.

Authors:  B J Lange; N Kobrinsky; D R Barnard; D C Arthur; J D Buckley; W B Howells; S Gold; J Sanders; S Neudorf; F O Smith; W G Woods
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

Review 9.  GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.

Authors:  John D Crispino
Journal:  Pediatr Blood Cancer       Date:  2005-01       Impact factor: 3.167

10.  Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.

Authors:  K N Canfield; L G Spector; L L Robison; D Lazovich; M Roesler; A F Olshan; F O Smith; N A Heerema; D R Barnard; C K Blair; J A Ross
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

View more
  2 in total

Review 1.  Malignancy in children with trisomy 21.

Authors:  Karen R Rabin; James A Whitlock
Journal:  Oncologist       Date:  2009-01-28

Review 2.  Vitamin C and immune cell function in inflammation and cancer.

Authors:  Abel Ang; Juliet M Pullar; Margaret J Currie; Margreet C M Vissers
Journal:  Biochem Soc Trans       Date:  2018-10-08       Impact factor: 5.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.